Author Correction: Schizophrenia risk from complex variation of complement component 4 (Nature, (2016), 530, 7589, (177-183), 10.1038/nature16549);Schizophrenia risk from complex variation of complement component 4

Nature

Volumn 530, Issue 7589, 2016, Pages 177-183

  Sekar, Aswin ^a,b   Bialas, Allison R ^c   De Rivera, Heather ^a,b   Davis, Avery ^a,b   Hammond, Timothy R ^c   Kamitaki, Nolan ^a,b   Tooley, Katherine ^a,b   Presumey, Jessy ^c   Baum, Matthew ^a,b,c   Van Doren, Vanessa ^a   Genovese, Giulio ^a,b   Rose, Samuel A ^b   Handsaker, Robert E ^a,b   Daly, Mark J ^b,d   Carroll, Michael C ^c   Stevens, Beth ^b,c   McCarroll, Steven A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C4B; GENOMIC DNA; RNA; MESSENGER RNA;

ALLELE; GENE EXPRESSION; HEALTH RISK; MAJOR HISTOCOMPATIBILITY COMPLEX; MENTAL HEALTH; NERVOUS SYSTEM DISORDER; PROTEIN;

ALLELE; ARTICLE; CELL BODY; COPY NUMBER VARIATION; DENDRITE; GENE EXPRESSION; GENE LOCUS; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HLA SYSTEM; HUMAN; HUMAN CHROMOSOME; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RISK FACTOR; SCHIZOPHRENIA; SYNAPSE; AMINO ACID SEQUENCE; ANIMAL; ANIMAL MODEL; AXON; BRAIN; CHEMISTRY; COMPLEMENT CLASSICAL PATHWAY; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; METABOLISM; MOUSE; NERVE CELL PLASTICITY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

MUS;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; AXONS; BASE SEQUENCE; BRAIN; COMPLEMENT C4; COMPLEMENT PATHWAY, CLASSICAL; DENDRITES; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAPLOTYPES; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MODELS, ANIMAL; NEURONAL PLASTICITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; RNA, MESSENGER; SCHIZOPHRENIA; SYNAPSES;

EID: 84958074030     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/s41586-021-04202-x     Document Type: Erratum

References (56)

1. Cannon, T. D. et al. Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc. Natl Acad. Sci. USA 99, 3228-3233 (2002).
2. Cannon, T. D. et al. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol. Psychiatry 77, 147-157 (2015).
3. Garey, L. J. et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J. Neurol. Neurosurg. Psychiatry 65, 446-453 (1998).
4. Glantz, L. A., Lewis, D. A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57, 65-73 (2000).
5. Glausier, J. R., Lewis, D. A. Dendritic spine pathology in schizophrenia. Neuroscience 251, 90-107 (2013).
6. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427 (2014).
7. Shi, J. et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460, 753-757 (2009).
8. Stefansson, H. et al. Common variants conferring risk of schizophrenia. Nature 460, 744-747 (2009).
9. International Schizophrenia Consortium et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752 (2009).
10. Schizophrenia Psychiatric Genome-Wide Association Study Consortium. Genome-wide association study identifies five new schizophrenia loci. Nature Genet. 43, 969-976 (2011).
11. Howson, J. M., Walker, N. M., Clayton, D., Todd, J. A. Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes Obes. Metab. 11 (Suppl 1), 31-45 (2009).
12. Raychaudhuri, S. et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nature Genet. 44, 291-296 (2012).
13. Escudero-Esparza, A., Kalchishkova, N., Kurbasic, E., Jiang, W. G., Blom, A. M. The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly. FASEB J. 27, 5083-5093 (2013).
14. Carroll, M. C., Campbell, R. D., Bentley, D. R., Porter, R. R. A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature 307, 237-241 (1984).
15. Carroll, M. C., Belt, T., Palsdottir, A., Porter, R. R. Structure and organization of the C4 genes. Phil. Trans. R. Soc. Lond. B 306, 379-388 (1984).
16. Dangel, A. W. et al. The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates. Immunogenetics 40, 425-436 (1994).
17. Horton, R. et al. Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics 60, 1-18 (2008).
18. Bánlaki, Z., Doleschall, M., Rajczy, K., Fust, G., Szilagyi, A. Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes. Genes Immun. 13, 530-535 (2012).
19. Law, S. K., Dodds, A. W., Porter, R. R. A comparison of the properties of two classes, C4A and C4B, of the human complement component C4. EMBO J. 3, 1819-1823 (1984).
20. Isenman, D. E., Young, J. R. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4. J. Immunol. 132, 3019-3027 (1984).
21. Illarionova, A. E., Vinogradova, T. V., Sverdlov, E. D. Only those genes of the KIAA1245 gene subfamily that contain HERV(K) LTRs in their introns are transcriptionally active. Virology 358, 39-47 (2007).
22. Nakamura, A., Okazaki, Y., Sugimoto, J., Oda, T., Jinno, Y. Human endogenous retroviruses with transcriptional potential in the brain. J. Hum. Genet. 48, 575-581 (2003).
23. Suntsova, M. et al. Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH. Proc. Natl Acad. Sci. USA 110, 19472-19477 (2013).
24. Yang, Y. et al. Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index. J. Immunol. 171, 2734-2745 (2003).
25. Browning, S. R., Browning, B. L. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am. J. Hum. Genet. 81, 1084-1097 (2007).
26. Iossifov, I. et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515, 216-221 (2014).
27. Mayilyan, K. R., Arnold, J. N., Presanis, J. S., Soghoyan, A. F., Sim, R. B. Increased complement classical and mannan-binding lectin pathway activities in schizophrenia. Neurosci. Lett. 404, 336-341 (2006).
28. Hakobyan, S., Boyajyan, A., Sim, R. B. Classical pathway complement activity in schizophrenia. Neurosci. Lett. 374, 35-37 (2005).
29. Stevens, B. et al. The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164-1178 (2007).
30. Schafer, D. P. et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74, 691-705 (2012).
31. Bialas, A. R., Stevens, B. TGF-β signaling regulates neuronal C1q expression and developmental synaptic refinement. Nature Neurosci. 16, 1773-1782 (2013).
32. Kaiser, T., Feng, G. Modeling psychiatric disorders for developing effective treatments. Nature Med. 21, 979-988 (2015).
33. Shatz, C. J., Kirkwood, P. A. Prenatal development of functional connections in the cat's retinogeniculate pathway. J. Neurosci. 4, 1378-1397 (1984).
34. Sretavan, D. W., Shatz, C. J. Prenatal development of retinal ganglion cell axons: segregation into eye-specific layers within the cat's lateral geniculate nucleus. J. Neurosci. 6, 234-251 (1986).
35. Chen, C., Regehr, W. G. Developmental remodeling of the retinogeniculate synapse. Neuron 28, 955-966 (2000).
36. Fischer, M. B. et al. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157, 549-556 (1996).
37. Huttenlocher, P. R., Dabholkar, A. S. Regional differences in synaptogenesis in human cerebral cortex. J. Comp. Neurol. 387, 167-178 (1997).
38. Huttenlocher, P. R. Synaptic density in human frontal cortex-developmental changes and effects of aging. Brain Res. 163, 195-205 (1979).
39. Petanjek, Z. et al. Extraordinary neoteny of synaptic spines in the human prefrontal cortex. Proc. Natl Acad. Sci. USA 108, 13281-13286 (2011).
40. Buckner, R. L., Krienen, F. M. The evolution of distributed association networks in the human brain. Trends Cogn. Sci. 17, 648-665 (2013).
41. Feinberg, I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J. Psychiatr. Res. 17, 319-334 (1982-1983).
42. Kirov, G. et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 17, 142-153 (2012).
43. Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179-184 (2014).
44. Purcell, S. M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185-190 (2014).
45. Datwani, A. et al. Classical MHCI molecules regulate retinogeniculate refinement and limit ocular dominance plasticity. Neuron 64, 463-470 (2009).
46. Lee, H. et al. Synapse elimination and learning rules co-regulated by MHC class I H2-Db. Nature 509, 195-200 (2014).
47. van den Elsen, J. M. et al. X-ray crystal structure of the C4d fragment of human complement component C4. J. Mol. Biol. 322, 1103-1115 (2002).
48. Dodds, A. W., Ren, X. D., Willis, A. C., Law, S. K. The reaction mechanism of the internal thioester in the human complement component C4. Nature 379, 177-179 (1996).
49. Handsaker, R. E. et al. Large multiallelic copy number variations in humans. Nature Genet. 47, 296-303 (2015).
50. Torborg, C. L., Feller, M. B. Unbiased analysis of bulk axonal segregation patterns. J. Neurosci. Methods 135, 17-26 (2004).
51. Fernando, M. M. et al. Assessment of complement C4 gene copy number using the paralog ratio test. Hum. Mutat. 31, 866-874 (2010).
52. Rudduck, C., Beckman, L., Franzen, G., Jacobsson, L., Lindstrom, L. Complement factor C4 in schizophrenia. Hum. Hered. 35, 223-226 (1985).
53. Schroers, R. et al. Investigation of complement C4B deficiency in schizophrenia. Hum. Hered. 47, 279-282 (1997).
54. Mayilyan, K. R., Dodds, A. W., Boyajyan, A. S., Soghoyan, A. F., Sim, R. B. Complement C4B protein in schizophrenia. World J. Biol. Psychiatry 9, 225-230 (2008).
55. Jia, X. et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS ONE 8, e64683 (2013).
56. Nonaka, M., Nakayama, K., Yeul, Y. D., Takahashi, M. Complete nucleotide and derived amino acid sequences of sex-limited protein (Slp), nonfunctional isotype of the fourth component of mouse complement (C4). J. Immunol. 136, 2989-2993 (1986).